PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia

35Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

The DNA methyltransferases DNMT3A and DNMT3B are primarily responsible for de novo methylation of specific cytosine residues in CpG dinucleotides during mammalian development. While loss-of-function mutations in DNMT3A are highly recurrent in acute myeloid leukemia (AML), DNMT3A mutations are almost never found in AML patients with translocations that create oncogenic fusion genes such as PML-RARA, RUNX1-RUNX1T1, and MLL-AF9. Here, we explored how DNMT3A is involved in the function of these fusion genes. We used retroviral vectors to express PML-RARA, RUNX1-RUNX1T1, or MLL-AF9 in bone marrow cells derived from WT or DNMT3A-deficient mice. Additionally, we examined the phenotypes of hematopoietic cells from Ctsg-PML-RARA mice, which express PML-RARA in early hematopoietic progenitors and myeloid precursors, with or without DNMT3A. We determined that the methyltransferase activity of DNMT3A, but not DNMT3B, is required for aberrant PML-RARA-driven self-renewal ex vivo and that DNMT3A is dispensable for RUNX1-RUNX1T1- and MLL-AF9-driven self-renewal. Furthermore, both the PML-RARA-driven competitive transplantation advantage and development of acute promyelocytic leukemia (APL) required DNMT3A. Together, these findings suggest that PML-RARA requires DNMT3A to initiate APL in mice.

References Powered by Scopus

Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

8778Citations
N/AReaders
Get full text

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

6738Citations
N/AReaders
Get full text

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

4932Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure

233Citations
N/AReaders
Get full text

CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression

163Citations
N/AReaders
Get full text

Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies

76Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cole, C. B., Verdoni, A. M., Ketkar, S., Leight, E. R., Russler-Germain, D. A., Lamprecht, T. L., … Ley, T. J. (2016). PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia. Journal of Clinical Investigation, 126(1), 85–98. https://doi.org/10.1172/JCI82897

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

53%

Researcher 14

41%

Professor / Associate Prof. 2

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 18

44%

Agricultural and Biological Sciences 16

39%

Medicine and Dentistry 6

15%

Earth and Planetary Sciences 1

2%

Save time finding and organizing research with Mendeley

Sign up for free